Results 141 to 150 of about 961,470 (198)

Deoxycytidine kinase inhibition: Rewiring tumor nucleotide metabolism for therapeutic gain. [PDF]

Nucleosides Nucleotides Nucleic Acids
Clark PM, Thompson CB, Schultz KA.
europepmc   +1 more source

Prevalence of parvovirus B19 infection in patients with hematological diseases in the Western Brazilian Amazon. [PDF]

Hematol Transfus Cell Ther
de Souza PHR, Barbosa AN, de Oliveira LC, Mineiro LS, de Abreu RS, Alves CEC, Mejía MDCC, Naveca FG, Pontes GS.   +8 more
europepmc   +1 more source

Unraveling Let-7f in oncology: a tumor suppressor with emerging clinical significance. [PDF]

Front Cell Dev Biol
Deng J, Li D, Li Z, Pan Y, Zeng X.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Plasma cell leukemia

Current Treatment Options in Oncology, 2001
Plasma cell leukemia (PCL) is a rare aggressive variant of multiple myeloma (MM) characterized by a fulminant course and poor prognosis. The median survival is measured in months. Therapy and prognosis partially depend on whether the disease presents de novo or as a secondary process involving the leukemic transformation of a previously diagnosed MM ...
S R, Hayman, R, Fonseca
openaire   +2 more sources

Plasma cell leukemia in pregnancy

Blood, 2012
![Figure][1] A 35-year-old multigravida with a 24-week pregnancy presented with generalized weakness and altered sensorium for 2 weeks. Physical examination revealed pallor and an enlarged uterus corresponding to gestational age.
Bushra, Moiz, Syed Sarwar, Ali
openaire   +2 more sources

Plasmacytomas and Plasma-Cell Leukemia

New England Journal of Medicine, 2017
A 63-year-old man with multiple myeloma who had received extensive treatment for the condition presented with lesions on his arms and chest wall. Biopsy revealed plasmacytomas. Peripheral-blood smear revealed 25% plasma cells.
Uqba, Khan, Tarik, Hadid
openaire   +2 more sources

Plasma cell leukemia with myelofibrosis

Annals of Hematology, 1994
We describe a case of plasma cell leukemia associated with myelofibrosis. A 60-year-old woman was admitted due to lumbago and monoclonal hypergammaglobulinemia. Peripheral blood showed about 40% of plasma-cell-like cells. A bone marrow aspiration was dry tap.
T. Murayama, T. Matsui, Y. Hayashi, T. Taniguchi, M. Ito, T. Natazuka, S. Imoto, N. Iwata, T. Isobe, H. Ito, K. Chihara   +10 more
openaire   +2 more sources

Bortezomib and Plasma Cell Leukemia.

Blood, 2006
Abstract Bortezomib (Velcade) is currently approved in USA and EU for the treatment of resistant/relapsed multiple mieloma (MM). Some reports have suggested that bortezomib is particularly effective for the treatment of extramedullary MM. However, there are very few data about the efficacy of this drug in plasma cell leukemia (PCL), a MM
Pellegrino Musto, Marialucia Barone, Roberto Guariglia, Giuseppe Pietrantuono, Francesca Gay, Fausto Rossini, Tommasina Guglielmelli, Vincenzo Pitini, Felicetto Ferrara, Monica Galli, Antonietta Falcone, POZZI, Samantha, Fiorella D’auria, SACCHI, Stefano, Mario Boccadoro, Antonio Palumbo   +15 more
openaire   +1 more source

Global methylation patterns in primary plasma cell leukemia.

Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis, 2018
Primary plasma cell leukemia (pPCL) is a rare and very aggressive variant of multiple myeloma (MM). Specific clinical, biological and molecular patterns distinguish pPCL from MM. Here, we performed a genome-wide methylation analysis by high-density array
K. Todoerti, G. Calice, Stefania Trino, V. Simeon, Marta Lionetti, M. Manzoni, S. Fabris, M. Barbieri, A. Pompa, L. Baldini, V. Bollati, P. Zoppoli, A. Neri, P. Musto   +13 more
semanticscholar   +1 more source